---
title: "Wall Street Warning: 'Sell' Penny Stock Beyond Meat (BYND), Analysts See Up to 40% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285927151.md"
description: "Beyond Meat (BYND) shares fell over 6% to $0.83 after its Q1 2026 results, prompting analysts to issue warnings about significant downside risks. Barclays analyst Benjamin Theurer maintained a Sell rating with a price target of $0.50, indicating nearly 40% downside, citing weak demand and lack of guidance. TD Cowen's Robert Moskow also reiterated a Sell rating with a $0.60 target, suggesting 28% downside, as the company reported a 15% revenue decline and expects further deterioration in Q2. Analysts have a Moderate Sell consensus on BYND stock."
datetime: "2026-05-11T10:45:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285927151.md)
  - [en](https://longbridge.com/en/news/285927151.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285927151.md)
---

# Wall Street Warning: 'Sell' Penny Stock Beyond Meat (BYND), Analysts See Up to 40% Downside

Beyond Meat (BYND), the plant-based meat company, recently reported its first-quarter 2026 results, but Wall Street remains highly cautious on this penny stock. Shares fell more than 6% to around $0.83 after the report, as analysts at TD Cowen and Barclays warned that weakening demand trends and ongoing execution risks could push the stock even lower.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

## **Barclays Warns of Nearly 40% Downside**

Following the earnings release, Barclays analyst Benjamin Theurer maintained a Sell-equivalent Underweight rating on BYND stock and kept his price target at just $0.50. That target suggests nearly 40% downside from current trading levels.

Theurer pointed to persistent weakness in the company's U.S. retail and foodservice businesses, where sales volumes continue to decline. He also noted that management did not provide full-year guidance, signaling limited visibility into a near-term recovery.

## **TD Cowen Sees Nearly 28% Downside for BYND Stock**

Likewise, TD Cowen analyst Robert Moskow also reiterated a Sell rating on Beyond Meat stock with a $0.60 price target. The target implies roughly 28% downside from current levels.

Moskow said the company continues to show "deterioration" across key business metrics. Beyond Meat reported a 15% decline in revenue during the quarter, driven mainly by a sharp 20% drop in sales volume.

The analyst also expects another double-digit percentage decline in Q2, pointing to continued weakness across the plant-based food category.

## **Is Beyond Meat a Good Stock to Buy?**

Turning to Wall Street, analysts have a Moderate Sell consensus rating on BYND stock based on three Holds and three Sells assigned in the past three months. Further, the average BYND price target of $0.66 per share implies 20.78% downside potential.

### Related Stocks

- [BYND.US](https://longbridge.com/en/quote/BYND.US.md)
- [PBJ.US](https://longbridge.com/en/quote/PBJ.US.md)
- [FTXG.US](https://longbridge.com/en/quote/FTXG.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)

## Related News & Research

- [Krispy Kreme (DNUT) Gets a Hold from Citi](https://longbridge.com/en/news/286686686.md)
- [DNB Asset Management AS Increases Stock Holdings in Kraft Heinz Company $KHC](https://longbridge.com/en/news/286732802.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)